Related Experiment Video
Updated: Apr 21, 2026

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
Accumulation of aberrant DNA methylation during colorectal cancer development
Eiji Sakai1, Atsushi Nakajima1, Atsushi Kaneda1
1Eiji Sakai, Atsushi Nakajima, Department of Gastroenterology, Yokohama City University School of Medicine, Yokohama 236-0027, Japan.
Abstract:
Despite the recent advances in the therapeutic modalities, colorectal cancer (CRC) remains to be one of the most common causes of cancer-related death. CRC arises through accumulation of multiple genetic and epigenetic alterations that transform normal colonic epithelium into adenocarcinomas. Among crucial roles of epigenetic alterations, gene silencing by aberrant DNA methylation of promoter regions is one of the most important epigenetic mechanisms. Recent comprehensive methylation analyses on genome-wide scale revealed that sporadic CRC can be classified into distinct epigenotypes. Each epigenotype cooperates with specific genetic alterations, suggesting that they represent different molecular carcinogenic pathways. Precursor lesions of CRC, such as conventional and serrated adenomas, already show similar methylation accumulation to CRC, and can therefore be classified into those epigenotypes of CRC. In addition, specific DNA methylation already occurs in the normal colonic mucosa, which might be utilized for prediction of the personal CRC risk. DNA methylation is suggested to occur at an earlier stage than carcinoma formation, and may predict the molecular basis for future development of CRC. Here, we review DNA methylation and CRC classification, and discuss the possible clinical usefulness of DNA methylation as biomarkers for the diagnosis, prediction of the prognosis and the response to therapy of CRC.
Insights
DNA methylation patterns classify colorectal cancer (CRC) subtypes and may predict cancer risk. This epigenetic mechanism is crucial for early detection and personalized treatment strategies for colorectal cancer.
Area of Science:
- Epigenetics
- Molecular Oncology
- Cancer Genomics
Background:
- Colorectal cancer (CRC) remains a leading cause of cancer mortality despite therapeutic advances.
- CRC development involves accumulating genetic and epigenetic alterations, notably gene silencing via aberrant DNA methylation.
- DNA methylation plays a critical role in the epigenetic landscape of colorectal cancer.
Purpose of the Study:
- To review the role of DNA methylation in classifying colorectal cancer (CRC).
- To explore the potential clinical utility of DNA methylation as biomarkers for CRC diagnosis, prognosis, and therapy response.
- To discuss how DNA methylation patterns in normal colonic mucosa may predict individual CRC risk.
Main Methods:
- Genome-wide methylation analyses to classify sporadic CRC into distinct epigenotypes.
- Analysis of methylation patterns in precursor lesions (adenomas) and normal colonic mucosa.
- Review of existing literature on DNA methylation and CRC.
Main Results:
- Sporadic CRC can be categorized into distinct epigenotypes, each associated with specific genetic alterations, indicating different carcinogenic pathways.
- Precursor lesions like conventional and serrated adenomas exhibit methylation accumulation similar to CRC, aligning with these epigenotypes.
- Aberrant DNA methylation occurs early, even in normal colonic mucosa, suggesting its potential for predicting CRC risk.
Conclusions:
- DNA methylation is a key epigenetic mechanism driving CRC development and classification.
- Epigenotypes identified through methylation analysis offer insights into distinct molecular pathways of CRC.
- DNA methylation holds significant promise as a biomarker for early diagnosis, prognosis prediction, and guiding therapy response in colorectal cancer.
Related Concept Videos
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Epigenetic Regulation
X-chromosome...

